The original patent submission was filed by US Cellular Dynamics International (CDI), now a subsidiary of Fujifilm, and claims the production of induced pluripotent stem cells from a small amount of peripheral blood using an episomal vector. The claims overlap to some extent with claims of CiRA, Kyoto University.
Fujifilm news release, October 19, 2016
Fujifilm obtains broad patent protection in Japan to produce iPS cells from peripheral blood